Suspected posaconazole toxicity in a pediatric oncology patient

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|9|1682-1682

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.9, 2015-09, pp. : 1682-1682

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Posaconazole oral dose and plasma levels in pediatric hematology‐oncology patients

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 3, 2018-03 ,pp. : 315-322

John Wiley & Sons Inc

Access to resources Recommend Favorite

Suspected piperacillin‐tazobactam induced nephrotoxicity in the pediatric oncology population

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 2, 2014-02 ,pp. : 366-368

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient‐controlled analgesia at the end of life at a pediatric oncology institution

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 7, 2015-07 ,pp. : 1237-1244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Disparities in pediatric oncology patient education and linguistic resources: Results of a national survey of pediatric oncologists

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 2, 2014-02 ,pp. : 333-336

John Wiley & Sons Inc

Access to resources Recommend Favorite

Orthodontic strategies in pediatric oncology

By Boyer É.   Robert G.   Gandemer V.   Bonnaure-Mallet M.  

Journal of Dentofacial Anomalies and Orthodontics, Vol. 20, Iss. 1, 2018-04 ,pp. : 104-104

Edp Sciences

Access to resources Recommend Favorite